{"entity":{"type":"insider","cik":"0001843594","url":"/insider/0001843594","json_url":"/insider/0001843594.json","name":"Peyer James","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":74,"n_filings":50,"first":"2021-02-19","last":"2026-06-01","span_basis":"filed_date"},"name_variants":[{"name":"Peyer James","source":"filing","n_filings":50,"first_seen":"2021-02-19","last_seen":"2026-06-01"}],"transactions":[{"id":5914780,"accession":"0000897069-26-001297","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000897069-26-001297","line_url":"/filing/0000897069-26-001297","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Ten percent owner, Other","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":20.0217056,"price_display":"20.02","price_state":"stated","total_value":500542.64,"total_display":"500,542.64","total_whole":"500,543","shares_owned_after":130618.0,"shares_owned_after_display":"130,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-01","scope":"insider","n_lines":2},{"id":4488043,"accession":"0000897069-25-001793","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000897069-25-001793","line_url":"/filing/0000897069-25-001793","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Ten percent owner, Other","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3507.0,"shares_display":"3,507","price_per_share":7.956321642429427,"price_display":"7.96","price_state":"stated","total_value":27902.82,"total_display":"27,902.82","total_whole":"27,903","shares_owned_after":155588.0,"shares_owned_after_display":"155,588","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-09","filed_date":"2025-12-10","scope":"insider","n_lines":3},{"id":4488027,"accession":"0000897069-25-001793","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-25-001793","line_url":"/filing/0000897069-25-001793#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Ten percent owner, Other","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3105.0,"shares_display":"3,105","price_per_share":8.59,"price_display":"8.59","price_state":"stated","total_value":26671.95,"total_display":"26,671.95","total_whole":"26,672","shares_owned_after":158254.0,"shares_owned_after_display":"158,254","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-10","scope":"insider"},{"id":4746540,"accession":"0000897069-25-001774","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000897069-25-001774","line_url":"/filing/0000897069-25-001774","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Ten percent owner, Other","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16295.0,"shares_display":"16,295","price_per_share":11.499844737649585,"price_display":"11.50","price_state":"stated","total_value":187389.97,"total_display":"187,389.97","total_whole":"187,390","shares_owned_after":163146.0,"shares_owned_after_display":"163,146","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-05","filed_date":"2025-12-08","scope":"insider","n_lines":3},{"id":4746527,"accession":"0000897069-25-001774","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-25-001774","line_url":"/filing/0000897069-25-001774#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Ten percent owner, Other","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":9.06,"price_display":"9.06","price_state":"stated","total_value":45300.0,"total_display":"45,300.00","total_whole":"45,300","shares_owned_after":177654.0,"shares_owned_after_display":"177,654","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-04","filed_date":"2025-12-08","scope":"insider"},{"id":9292169,"accession":"0001567619-22-012647","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-012647","line_url":"/filing/0001567619-22-012647#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1203.0,"shares_display":"1,203","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":3849.6,"total_display":"3,849.60","total_whole":"3,850","shares_owned_after":5231488.0,"shares_owned_after_display":"5,231,488","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-02","filed_date":"2022-06-10","scope":"insider"},{"id":6784038,"accession":"0001567619-22-006006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-006006","line_url":"/filing/0001567619-22-006006#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1203.0,"shares_display":"1,203","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":3849.6,"total_display":"3,849.60","total_whole":"3,850","shares_owned_after":5231989.0,"shares_owned_after_display":"5,231,989","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-02","filed_date":"2022-03-02","scope":"insider"},{"id":6226726,"accession":"0001567619-22-005915","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-005915","line_url":"/filing/0001567619-22-005915#line-2","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2458.0,"shares_display":"2,458","price_per_share":3.6,"price_display":"3.60","price_state":"stated","total_value":8848.8,"total_display":"8,848.80","total_whole":"8,849","shares_owned_after":5230786.0,"shares_owned_after_display":"5,230,786","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-01","filed_date":"2022-03-01","scope":"insider"},{"id":6226721,"accession":"0001567619-22-005915","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-005915","line_url":"/filing/0001567619-22-005915#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":42.0,"shares_display":"42","price_per_share":3.6,"price_display":"3.60","price_state":"stated","total_value":151.2,"total_display":"151.20","total_whole":"151","shares_owned_after":5228328.0,"shares_owned_after_display":"5,228,328","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-28","filed_date":"2022-03-01","scope":"insider"},{"id":6394409,"accession":"0001567619-22-005792","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-005792","line_url":"/filing/0001567619-22-005792#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":3.65,"price_display":"3.65","price_state":"stated","total_value":9125.0,"total_display":"9,125.00","total_whole":"9,125","shares_owned_after":5228286.0,"shares_owned_after_display":"5,228,286","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-25","filed_date":"2022-02-28","scope":"insider"},{"id":6133357,"accession":"0001567619-22-005517","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-005517","line_url":"/filing/0001567619-22-005517#line-2","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":3.63,"price_display":"3.63","price_state":"stated","total_value":54450.0,"total_display":"54,450.00","total_whole":"54,450","shares_owned_after":5225786.0,"shares_owned_after_display":"5,225,786","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-24","filed_date":"2022-02-24","scope":"insider"},{"id":6133353,"accession":"0001567619-22-005517","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-005517","line_url":"/filing/0001567619-22-005517#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":3.8,"price_display":"3.80","price_state":"stated","total_value":9500.0,"total_display":"9,500.00","total_whole":"9,500","shares_owned_after":5210786.0,"shares_owned_after_display":"5,210,786","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-23","filed_date":"2022-02-24","scope":"insider"},{"id":6783932,"accession":"0001567619-22-005191","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-005191","line_url":"/filing/0001567619-22-005191#line-2","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":3.97,"price_display":"3.97","price_state":"stated","total_value":59550.0,"total_display":"59,550.00","total_whole":"59,550","shares_owned_after":5208286.0,"shares_owned_after_display":"5,208,286","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-18","filed_date":"2022-02-22","scope":"insider"},{"id":6783926,"accession":"0001567619-22-005191","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-005191","line_url":"/filing/0001567619-22-005191#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4949.0,"shares_display":"4,949","price_per_share":4.17,"price_display":"4.17","price_state":"stated","total_value":20637.33,"total_display":"20,637.33","total_whole":"20,637","shares_owned_after":5193286.0,"shares_owned_after_display":"5,193,286","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-17","filed_date":"2022-02-22","scope":"insider"},{"id":6828279,"accession":"0001567619-22-004777","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-004777","line_url":"/filing/0001567619-22-004777#line-2","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2551.0,"shares_display":"2,551","price_per_share":4.25,"price_display":"4.25","price_state":"stated","total_value":10841.75,"total_display":"10,841.75","total_whole":"10,842","shares_owned_after":5188337.0,"shares_owned_after_display":"5,188,337","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-16","filed_date":"2022-02-16","scope":"insider"},{"id":6828274,"accession":"0001567619-22-004777","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-004777","line_url":"/filing/0001567619-22-004777#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.18,"price_display":"4.18","price_state":"stated","total_value":41800.0,"total_display":"41,800.00","total_whole":"41,800","shares_owned_after":5185786.0,"shares_owned_after_display":"5,185,786","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-14","filed_date":"2022-02-16","scope":"insider"},{"id":6515861,"accession":"0001567619-22-004545","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-004545","line_url":"/filing/0001567619-22-004545#line-2","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":4.4,"price_display":"4.40","price_state":"stated","total_value":55000.0,"total_display":"55,000.00","total_whole":"55,000","shares_owned_after":5175786.0,"shares_owned_after_display":"5,175,786","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-11","filed_date":"2022-02-14","scope":"insider"},{"id":6515856,"accession":"0001567619-22-004545","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-004545","line_url":"/filing/0001567619-22-004545#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.58,"price_display":"4.58","price_state":"stated","total_value":22900.0,"total_display":"22,900.00","total_whole":"22,900","shares_owned_after":5163286.0,"shares_owned_after_display":"5,163,286","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-10","filed_date":"2022-02-14","scope":"insider"},{"id":6864134,"accession":"0001567619-22-002935","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-22-002935","line_url":"/filing/0001567619-22-002935#line-3","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.33,"price_display":"4.33","price_state":"stated","total_value":43300.0,"total_display":"43,300.00","total_whole":"43,300","shares_owned_after":5158286.0,"shares_owned_after_display":"5,158,286","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-08","filed_date":"2022-02-08","scope":"insider"},{"id":6864130,"accession":"0001567619-22-002935","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-002935","line_url":"/filing/0001567619-22-002935#line-2","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":4.45,"price_display":"4.45","price_state":"stated","total_value":11125.0,"total_display":"11,125.00","total_whole":"11,125","shares_owned_after":5148286.0,"shares_owned_after_display":"5,148,286","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-04","filed_date":"2022-02-08","scope":"insider"},{"id":6864126,"accession":"0001567619-22-002935","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-002935","line_url":"/filing/0001567619-22-002935#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17500.0,"shares_display":"17,500","price_per_share":4.65,"price_display":"4.65","price_state":"stated","total_value":81375.0,"total_display":"81,375.00","total_whole":"81,375","shares_owned_after":5145786.0,"shares_owned_after_display":"5,145,786","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-03","filed_date":"2022-02-08","scope":"insider"},{"id":6496050,"accession":"0001567619-22-002034","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-002034","line_url":"/filing/0001567619-22-002034#line-2","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8900.0,"shares_display":"8,900","price_per_share":4.22,"price_display":"4.22","price_state":"stated","total_value":37558.0,"total_display":"37,558.00","total_whole":"37,558","shares_owned_after":5128286.0,"shares_owned_after_display":"5,128,286","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-28","filed_date":"2022-01-31","scope":"insider"},{"id":6496048,"accession":"0001567619-22-002034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-002034","line_url":"/filing/0001567619-22-002034#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6100.0,"shares_display":"6,100","price_per_share":4.31,"price_display":"4.31","price_state":"stated","total_value":26291.0,"total_display":"26,291.00","total_whole":"26,291","shares_owned_after":5119386.0,"shares_owned_after_display":"5,119,386","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-27","filed_date":"2022-01-31","scope":"insider"},{"id":6459188,"accession":"0001567619-22-001804","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-001804","line_url":"/filing/0001567619-22-001804#line-2","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":29900.0,"shares_display":"29,900","price_per_share":4.62,"price_display":"4.62","price_state":"stated","total_value":138138.0,"total_display":"138,138.00","total_whole":"138,138","shares_owned_after":5113286.0,"shares_owned_after_display":"5,113,286","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-26","filed_date":"2022-01-27","scope":"insider"},{"id":6459186,"accession":"0001567619-22-001804","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-001804","line_url":"/filing/0001567619-22-001804#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20100.0,"shares_display":"20,100","price_per_share":4.86,"price_display":"4.86","price_state":"stated","total_value":97686.0,"total_display":"97,686.00","total_whole":"97,686","shares_owned_after":5083386.0,"shares_owned_after_display":"5,083,386","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-25","filed_date":"2022-01-27","scope":"insider"},{"id":6303774,"accession":"0001567619-22-001634","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-001634","line_url":"/filing/0001567619-22-001634#line-2","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22707.0,"shares_display":"22,707","price_per_share":4.69,"price_display":"4.69","price_state":"stated","total_value":106495.83,"total_display":"106,495.83","total_whole":"106,496","shares_owned_after":5063286.0,"shares_owned_after_display":"5,063,286","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-24","filed_date":"2022-01-25","scope":"insider"},{"id":6303771,"accession":"0001567619-22-001634","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-001634","line_url":"/filing/0001567619-22-001634#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24703.0,"shares_display":"24,703","price_per_share":4.94,"price_display":"4.94","price_state":"stated","total_value":122032.82,"total_display":"122,032.82","total_whole":"122,033","shares_owned_after":5040579.0,"shares_owned_after_display":"5,040,579","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-21","filed_date":"2022-01-25","scope":"insider"},{"id":6656186,"accession":"0001567619-22-001464","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-001464","line_url":"/filing/0001567619-22-001464#line-2","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":5.17,"price_display":"5.17","price_state":"stated","total_value":103400.0,"total_display":"103,400.00","total_whole":"103,400","shares_owned_after":5015876.0,"shares_owned_after_display":"5,015,876","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-20","filed_date":"2022-01-21","scope":"insider"},{"id":6656183,"accession":"0001567619-22-001464","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-001464","line_url":"/filing/0001567619-22-001464#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10244.0,"shares_display":"10,244","price_per_share":4.97,"price_display":"4.97","price_state":"stated","total_value":50912.68,"total_display":"50,912.68","total_whole":"50,913","shares_owned_after":4995876.0,"shares_owned_after_display":"4,995,876","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-19","filed_date":"2022-01-21","scope":"insider"},{"id":6864059,"accession":"0001567619-22-001342","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-001342","line_url":"/filing/0001567619-22-001342#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":5.08,"price_display":"5.08","price_state":"stated","total_value":50800.0,"total_display":"50,800.00","total_whole":"50,800","shares_owned_after":4985632.0,"shares_owned_after_display":"4,985,632","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-18","filed_date":"2022-01-20","scope":"insider"},{"id":6394210,"accession":"0001567619-22-001230","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-001230","line_url":"/filing/0001567619-22-001230#line-2","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6219.0,"shares_display":"6,219","price_per_share":4.99,"price_display":"4.99","price_state":"stated","total_value":31032.81,"total_display":"31,032.81","total_whole":"31,033","shares_owned_after":4975632.0,"shares_owned_after_display":"4,975,632","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-14","filed_date":"2022-01-18","scope":"insider"},{"id":6394203,"accession":"0001567619-22-001230","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-001230","line_url":"/filing/0001567619-22-001230#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19953.0,"shares_display":"19,953","price_per_share":5.13,"price_display":"5.13","price_state":"stated","total_value":102358.89,"total_display":"102,358.89","total_whole":"102,359","shares_owned_after":4969413.0,"shares_owned_after_display":"4,969,413","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-13","filed_date":"2022-01-18","scope":"insider"},{"id":6937936,"accession":"0001567619-22-001167","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-001167","line_url":"/filing/0001567619-22-001167#line-2","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9202.0,"shares_display":"9,202","price_per_share":5.22,"price_display":"5.22","price_state":"stated","total_value":48034.44,"total_display":"48,034.44","total_whole":"48,034","shares_owned_after":4949460.0,"shares_owned_after_display":"4,949,460","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-12","filed_date":"2022-01-13","scope":"insider"},{"id":6937933,"accession":"0001567619-22-001167","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-001167","line_url":"/filing/0001567619-22-001167#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10845.0,"shares_display":"10,845","price_per_share":5.18,"price_display":"5.18","price_state":"stated","total_value":56177.1,"total_display":"56,177.10","total_whole":"56,177","shares_owned_after":4940258.0,"shares_owned_after_display":"4,940,258","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-11","filed_date":"2022-01-13","scope":"insider"},{"id":6698183,"accession":"0001567619-22-001007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-001007","line_url":"/filing/0001567619-22-001007#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":5.28,"price_display":"5.28","price_state":"stated","total_value":52800.0,"total_display":"52,800.00","total_whole":"52,800","shares_owned_after":4929413.0,"shares_owned_after_display":"4,929,413","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-10","filed_date":"2022-01-11","scope":"insider"},{"id":6627537,"accession":"0001567619-22-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-000008","line_url":"/filing/0001567619-22-000008#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1127.0,"shares_display":"1,127","price_per_share":4.85,"price_display":"4.85","price_state":"stated","total_value":5465.95,"total_display":"5,465.95","total_whole":"5,466","shares_owned_after":4919413.0,"shares_owned_after_display":"4,919,413","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-30","filed_date":"2022-01-03","scope":"insider"},{"id":5497411,"accession":"0001567619-21-022649","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-022649","line_url":"/filing/0001567619-21-022649#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":69000.0,"shares_display":"69,000","price_per_share":4.98,"price_display":"4.98","price_state":"stated","total_value":343620.0,"total_display":"343,620.00","total_whole":"343,620","shares_owned_after":4918286.0,"shares_owned_after_display":"4,918,286","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-29","filed_date":"2021-12-30","scope":"insider"},{"id":5228362,"accession":"0001567619-21-022593","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-022593","line_url":"/filing/0001567619-21-022593#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11288.0,"shares_display":"11,288","price_per_share":5.28,"price_display":"5.28","price_state":"stated","total_value":59600.64,"total_display":"59,600.64","total_whole":"59,601","shares_owned_after":4849286.0,"shares_owned_after_display":"4,849,286","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-28","filed_date":"2021-12-29","scope":"insider"},{"id":5381672,"accession":"0001567619-21-022540","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-022540","line_url":"/filing/0001567619-21-022540#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3712.0,"shares_display":"3,712","price_per_share":5.3,"price_display":"5.30","price_state":"stated","total_value":19673.6,"total_display":"19,673.60","total_whole":"19,674","shares_owned_after":4837998.0,"shares_owned_after_display":"4,837,998","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-27","filed_date":"2021-12-27","scope":"insider"},{"id":4736796,"accession":"0001567619-21-022520","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-022520","line_url":"/filing/0001567619-21-022520#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11000.0,"shares_display":"11,000","price_per_share":5.27,"price_display":"5.27","price_state":"stated","total_value":57970.0,"total_display":"57,970.00","total_whole":"57,970","shares_owned_after":4834286.0,"shares_owned_after_display":"4,834,286","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-23","scope":"insider"},{"id":5525138,"accession":"0001567619-21-022392","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-022392","line_url":"/filing/0001567619-21-022392#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":117.0,"shares_display":"117","price_per_share":5.29,"price_display":"5.29","price_state":"stated","total_value":618.93,"total_display":"618.93","total_whole":"619","shares_owned_after":4823286.0,"shares_owned_after_display":"4,823,286","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-17","filed_date":"2021-12-21","scope":"insider"},{"id":5497392,"accession":"0001567619-21-022339","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-022339","line_url":"/filing/0001567619-21-022339#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10925.0,"shares_display":"10,925","price_per_share":5.25,"price_display":"5.25","price_state":"stated","total_value":57356.25,"total_display":"57,356.25","total_whole":"57,356","shares_owned_after":4823169.0,"shares_owned_after_display":"4,823,169","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-16","filed_date":"2021-12-20","scope":"insider"},{"id":5121338,"accession":"0001567619-21-009211","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-009211","line_url":"/filing/0001567619-21-009211#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":350.0,"shares_display":"350","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":4200.0,"total_display":"4,200.00","total_whole":"4,200","shares_owned_after":4812244.0,"shares_owned_after_display":"4,812,244","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-05","filed_date":"2021-05-06","scope":"insider"},{"id":5260197,"accession":"0001567619-21-008410","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-008410","line_url":"/filing/0001567619-21-008410#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":385.0,"shares_display":"385","price_per_share":12.77,"price_display":"12.77","price_state":"stated","total_value":4916.45,"total_display":"4,916.45","total_whole":"4,916","shares_owned_after":4811894.0,"shares_owned_after_display":"4,811,894","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-20","filed_date":"2021-04-21","scope":"insider"},{"id":4187045,"accession":"0001567619-21-008359","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-008359","line_url":"/filing/0001567619-21-008359#line-1","is_derivative":false,"issuer_cik":"0001829802","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001829802","owner_cik":"0001843594","owner_name":"Peyer James","owner_display_name":"Peyer James","owner_url":"/insider/0001843594","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1965.0,"shares_display":"1,965","price_per_share":13.38,"price_display":"13.38","price_state":"stated","total_value":26291.7,"total_display":"26,291.70","total_whole":"26,292","shares_owned_after":4811509.0,"shares_owned_after_display":"4,811,509","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-19","filed_date":"2021-04-20","scope":"insider"}],"collapsed":true,"next_cursor":"2021-04-19|4187045","ledger_fault":false,"count":{"value":74,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":64,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":74},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001829802","name":"Sensei Biotherapeutics, Inc.","url":"/issuer/0001829802","role":"Director, Ten percent owner, Other","n_filings":50,"first_seen":"2021-02-19","last_seen":"2026-06-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001843594","retrieved_at":"2026-08-23T04:44:47+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}